MANNKIND CORP Other Long-term Debt, Current
MANNKIND CORP (MNKD) had Other Long-term Debt, Current of $8.97 million as of 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:OtherLongTermDebtCurrent · last filed 2020-02-25
- 2019-06-30: Other Long-term Debt, Current $8.97M.
- 2019-03-31: Other Long-term Debt, Current $11.38M.
- 2018-12-31: Other Long-term Debt, Current $11.30M.
- 2018-09-30: Other Long-term Debt, Current $14.20M.
| Period end | Other Long-term Debt, Current |
|---|---|
| 2019-06-30 | $8.97M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $11.38M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $11.30M 10-K · filed 2020-02-25 |
| 2018-09-30 | $14.20M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $38.00M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $43.65M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $52.74M 10-K · filed 2019-02-26 |
| 2017-09-30 | $57.94M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $57.48M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $71.80M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $71.34M 10-K · filed 2018-02-27 |
| 2016-09-30 | $70.89M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $75.45M 10-Q/A · filed 2016-08-10 |
| 2016-03-31 | $75.01M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $74.58M 10-K · filed 2017-03-16 |
| 2015-09-30 | $74.16M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $73.76M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $73.37M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $73.00M 10-K · filed 2016-03-15 |
| 2014-06-30 | $37.74M 10-Q · filed 2014-08-11 |
| 2013-12-31 | $102.30M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |